Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.

Item

http://www.wikidata.org/entity/Q34288360

Q34288360

about

Role of Statistical Random-Effects Linear Models in Personalized Medicine Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia.Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial.Individualizing drug dosage with longitudinal data.Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010.Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Genetic and Clinical Factors Affecting Plasma Clozapine Concentration Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.A review of clozapine safety.Factors predicting use of laxatives in outpatients stabilized on clozapine.Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey.Smoking cessation in patients with psychiatric disorders Prescribing clozapine and rifampicin: clinical impact of their interaction.The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia Biomarkers in schizophrenia: a brief conceptual consideration.Factors associated with response to clozapine in schizophrenia: a review.Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit.Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.A review of the use of clozapine levels to guide treatment and determine cause of death.Atypical antipsychotics: trends in analysis and sample preparation of various biological samples.Clozapine for the treatment of schizophrenia.Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.Adverse effects of clozapine in older patients: epidemiology, prevention and management.Determination of Plasma Concentration Reference Ranges for Risperidone and Paliperidone.Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels.ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapine.The influence of cytochrome P450 pharmacogenetics on disposition of common antidepressant and antipsychotic medications.Comparability of whole-blood and plasma clozapine and norclozapine concentrations.ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.

P2860

Q24617125-7478732B-B8FF-4CF7-A2E3-C540288409A6 Q26748476-57851D14-374E-4C0D-B9B6-154CC5ED2085 Q28079065-2D5134F1-E5F2-43C6-8A92-567B74581A9F Q28394341-70F006E8-66B4-4B1F-95A8-E7F0BF11969D Q30490990-748B0E93-DB94-437B-B608-1AB81E02C1BB Q30949176-A830CBDF-1805-4D53-9744-A0D26E506FFD Q31108602-CD807254-7516-4A33-BE85-DA1210157293 Q33571417-1F7C5B00-5124-4971-A0A3-96CA29814AE8 Q34196607-96A41993-4C30-4C39-B92B-93D7B020C7DA Q34322230-8135B9DF-507B-4571-B236-9048E72856B5 Q35015993-59B0C39F-21CD-4AE3-BE7C-C7EA4581A2AE Q35746655-EC324924-5A32-4A89-9EFE-0EED45A66F84 Q35948858-B8DA1BFD-62A3-40F2-9A00-0566E617A241 Q36024542-E32BF011-889F-411B-A95D-D3E1A96FEC08 Q36191044-729EA81D-1BFB-4073-8F20-FF4CC1CC33B3 Q36211684-5EA71EFE-B231-468F-8B26-45E368F1931B Q36294225-C6A09845-FD72-4CB0-B2B5-9C7325A52619 Q36474143-4CF83F14-D9E3-4368-A360-92C5F7004B3A Q36953235-630CD347-8336-4C7B-A44B-DC6FD78C0DDB Q37059617-980D1BF2-A889-47F2-B5B5-623AE920888C Q37075939-0D70EFD9-4BD6-4E33-9AE6-C438D42DAF2C Q37176633-B21635B0-E3FD-4A19-8541-5894B3CB8782 Q37300007-A41A5017-EFCE-4B34-A981-361EFA27D179 Q37410806-610F4B42-C8D8-403B-851D-F9E56D8FB752 Q37598900-7038F02B-7EF9-4227-A0E2-60C1EAA274E2 Q37649913-E6B85C75-3047-4B85-A0CA-9CAE9C18644A Q37710240-F1960B40-E8D0-4FE9-A976-BDFC2AAEF799 Q37887304-6FD9C5D9-5092-44FF-A1A2-DFEA26EB01C0 Q37983363-65879B28-81B5-4C73-8726-9663EE08EFAD Q38005440-CC11303E-2F0D-4CCA-B659-943AC89419A6 Q38026886-7146283A-7F0E-4B54-BE3B-F07833CB9871 Q38078561-80EB4991-76F0-4F98-BDBF-6CD0EA84E096 Q38099224-2A160F8E-0D94-4B9B-A10C-C9FE5AFAB324 Q38171350-88C76361-CE8A-429D-83D2-A6FCC9059E97 Q38725596-AADB1068-6536-43CF-87EB-DC45E1E1522F Q41628681-83DF5BEF-807E-4D2F-9B0F-AB18DFFE67BA Q41634218-916C2B07-DB4D-4402-85B6-5D0AD9959BE9 Q42047832-EDA20B78-D1C8-4896-8D78-9700C46710D6 Q42760063-ACDBCE8A-7B69-4619-B81B-FC6809669033 Q43296441-D110C0F1-8B54-4D8B-A166-1B289BE61DC3

P2860

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.

Item

http://www.wikidata.org/entity/Q34288360

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu